Evidence map›Paper›PMID 35675552›Full record

ArticleAmerican journal of respiratory and critical care medicine2022

Polarization-Sensitive Endobronchial Optical Coherence Tomography for Microscopic Imaging of Fibrosis in Interstitial Lung Disease.

Sreyankar Nandy, Sarita R Berigei, Colleen M Keyes, Ashok Muniappan, Hugh G Auchincloss, Michael Lanuti, Benjamin W Roop, Angela R Shih, Thomas V Colby, Benjamin D Medoff and 3 more

Open access · greenAbstract readLetter
In one paragraph

Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Endobronchial Optical Coherence Tomography as a Novel Method forAmerican journal of respiratory and critical care medicine · 2024
    Article
  9. Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary FibrosisAmerican journal of respiratory and critical care medicine · 2024
    Article
  10. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.American journal of respiratory and critical care medicine · 2024
    Article
  11. Article
  12. Article
  13. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.Annals of the American Thoracic Society · 2023
    Article
  14. Multimodal Diagnostics of Changes in Rat Lungs after Vaping.Diagnostics (Basel, Switzerland) · 2023
    Article
  15. Observational
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sreyankar NandyMassachusetts General Hospital Boston, Massachusetts.ORCID 0000-0002-2553-7109
Sarita R BerigeiMassachusetts General Hospital Boston, Massachusetts.
Colleen M KeyesMassachusetts General Hospital Boston, Massachusetts.
Ashok MuniappanMassachusetts General Hospital Boston, Massachusetts.
Hugh G AuchinclossMassachusetts General Hospital Boston, Massachusetts.
Michael LanutiMassachusetts General Hospital Boston, Massachusetts.
Benjamin W RoopMassachusetts General Hospital Boston, Massachusetts.
Angela R ShihMassachusetts General Hospital Boston, Massachusetts.
Thomas V ColbyMayo Clinic Arizona Scottsdale, Arizona.
Benjamin D MedoffMassachusetts General Hospital Boston, Massachusetts.
Melissa J SuterMassachusetts General Hospital Boston, Massachusetts.
Martin VilligerMassachusetts General Hospital Boston, Massachusetts.
Lida P HaririMassachusetts General Hospital Boston, Massachusetts.
Harvard University · USMassachusetts General Hospital · USMayo Clinic in Arizona · US

Funding

TRD3: Percutaneous and Interstitial ImagingP41EB015903 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Brett E Bouma · 2012 to 2026
$22.4M
In vivo endobronchial OCT for IPF diagnosis and therapy response assessmentR01HL152075 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2020 to 2024
$4.0M
Low risk in vivo diagnosis of IPF with optical imagingK23HL132120 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2016 to 2020
$896k
NHLBI NIH HHS K23HL132120NHLBI NIH HHS R01 HL152075NHLBI NIH HHS R01HL152075NIBIB NIH HHS P41 EB015903NIBIB NIH HHS P41EB015903
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung Diseases, InterstitialTomography, Optical CoherenceFibrosisHumans

Identifiers

PMID35675552
PMCPMC12042782
OpenAlexW4282913336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.